Management of Delta Hepatitis 45 Years after the Discovery of HDV

por Brillanti, Stefano
Publicado 2022

Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?”

por Capecchi, Pier Leopoldo, Lazzerini, Pietro Enea, Brillanti, Stefano
Publicado 2021

Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project

por Borghi, Claudio, Ciancio, Alessia, Gentile, Ivan, Perrone Filardi, Pasquale, Pasqualetti, Patrizio, Brillanti, Stefano
Publicado 2022

Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients

por Ravaioli, Federico, Colecchia, Antonio, Dajti, Elton, Marasco, Giovanni, Alemanni, Luigina Vanessa, Tamè, Mariarosa, Azzaroli, Francesco, Brillanti, Stefano, Mazzella, Giuseppe, Festi, Davide
Publicado 2018